Poulvac Procerta HVT-IBD

Authorised

This medicine is authorised for use in the European Union

turkey herpes virus, strain FC-126, expressing infectious bursal disease virus VP2 protein, live

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

Product details

• Name of medicine:
  Poulvac Procerta HVT-IBD
• Active substance:
  Turkey herpes virus, strain HVT-IBD, expressing infectious bursal disease virus VP2 protein, live
• International non-proprietary name (INN) or common name:
  turkey herpes virus, strain FC-126, expressing infectious bursal disease virus VP2 protein, live

Pharmacotherapeutic group

• Immunologicals for aves
• Live viral vaccines
• Avian herpes virus (marek’s disease) + avian infectious bursal disease virus (gumboro disease)

Authorisation details

• EMA product number:
  EMEA/V/C/006000

Assessment history

Initial marketing authorisation documents

CVMP summary of positive opinion for Poulvac Procerta HVT-IBD

AdoptedReference Number: EMA/CVMP/379398/2023